Blood tests for Alzheimer's disease: The impact of disease prevalence on test performance
Alzheimers Dement
.
2024 May;20(5):3661-3663.
doi: 10.1002/alz.13762.
Epub 2024 Mar 6.
Authors
Mari L DeMarco
1
2
,
Alicia Algeciras-Schimnich
3
,
Melissa M Budelier
4
5
Affiliations
1
Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
2
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
3
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
4
TriCore Reference Laboratories, Albuquerque, New Mexico, USA.
5
Department of Pathology, University of New Mexico, Albuquerque, New Mexico, USA.
PMID:
38447004
PMCID:
PMC11095438
DOI:
10.1002/alz.13762
No abstract available
Publication types
Letter
MeSH terms
Alzheimer Disease* / blood
Alzheimer Disease* / diagnosis
Alzheimer Disease* / epidemiology
Biomarkers / blood
Hematologic Tests
Humans
Prevalence